Granuloma clinical trials
The registry lists 23 studies for Granuloma across more than 10 countries. 4 are recruiting or about to start. 10 of them are mainly about Granuloma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its narrower condition Churg-Strauss Syndrome too: 84 studies, 21 open.
Get an email when these change. Save the Granuloma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (2) · aTyr Pharma, Inc. (2) · Shaheed Zulfiqar Ali Bhutto Medical University (2) · Children Hospital and Institute of Child Health, Lahore (1) · University of Colorado, Denver (1) · Novartis Pharmaceuticals (1) · Phillip Song, MD (1) · Semmelweis University (1)
What is being tested here
Drugs under test in Granuloma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Efzofitimod | 0 | 1 | 1 |
| Canakinumab | 0 | 0 | 1 |
| Povidone-Iodine | 0 | 0 | 1 |
| Silver Nitrate | 0 | 0 | 1 |
| Cyclophosphamide | 0 | 0 | 1 |
| Botulinum toxin type A | 0 | 0 | 1 |
Who these studies take
Of the 4 Granuloma studies recruiting now, 1 (25%) set no upper age limit and 2 (50%) stop at 75 or younger. 1 (25%) take children under 18. 0 (0%) are for women only and 1 (25%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (25%) | 1 (25%) |
| 18 | 2 (50%) | 3 (75%) |
| 30 | 2 (50%) | 3 (75%) |
| 40 | 2 (50%) | 3 (75%) |
| 50 | 2 (50%) | 3 (75%) |
| 65 | 2 (50%) | 3 (75%) |
| 75 | 1 (25%) | 2 (50%) |
| 85 | 1 (25%) | 1 (25%) |
Across all 23 studies, recruiting or not: 52% stop at 75 or younger and 43% at 65; 39% take children; 0% are for women only and 4% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT000014051 country
- MoMa Signature During GranulomatosisRecruitingNCT059166381 country
- Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in ChildrenRecruitingNCT07300865Not applicable1 country
- Hypercalcemia After Paraffin Oil InjectionRecruitingNCT042922881 country
- Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisCompletedNCT05415137Phase 39 countries
- PRF Membrane and Recovery After Periapical Surgery: A 3D Imaging StudyCompletedNCT06739200Not applicable1 country
- Silver Nitrate Versus Topical Steroid For Umbilical GranulomaCompletedNCT06363539Phase 21 country
- The Efficacy of Laser in Root Canal DisinfectionCompletedNCT05964686Phase 21 country
- Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination GranulomasCompletedNCT06130462Not applicable1 country
- Endobronchial Ultrasound Strain Elastography in SarcoidosisStatus unknownNCT048951111 country
- Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary SarcoidosisCompletedNCT03824392Phase 1/21 country
- Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control TrialCompletedNCT05545462Not applicable1 country
- Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.Status unknownNCT05534334Phase 2/31 country
- Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary SarcoidosisCompletedNCT02888080Phase 23 countries
- Treatment of Tracheostomy GranulomasCompletedNCT02116608Phase 41 country
- Double Ligation and Topical Silver NitrateCompletedNCT04248101Phase 2
- Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided ProceduresTerminatedNCT01287013Not applicable1 country
- Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold GranulomasWithdrawnNCT01678053Phase 21 country
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood CellsCompletedNCT00730314Phase 1/21 country
- Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and TherapyCompletedNCT019676931 country
- A Prospective Double-blind Interventional Study of Tissue Reaction to Polyglycolic Acid Sutures in Human SkinCompletedNCT01598376Not applicable1 country
- Simple Hygiene Versus Alcohol Based Usual Care for Umbilical CordStatus unknownNCT01369251Phase 31 country
- Treatment of Wegener's Granulomatosis With CyclophosphamideCompletedNCT00001155Phase 21 country